Cargando…
Correction to: Epac activation inhibits IL-6-induced cardiac myocyte dysfunction
Autores principales: | Jin, Huiling, Fujita, Takayuki, Jin, Meihua, Kurotani, Reiko, Hidaka, Yuko, Cai, Wenqian, Suita, Kenji, Prajapati, Rajesh, Liang, Chen, Ohnuki, Yoshiki, Mototani, Yasumasa, Umemura, Masanari, Yokoyama, Utako, Sato, Motohiko, Okumura, Satoshi, Ishikawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456467/ https://www.ncbi.nlm.nih.gov/pubmed/30762213 http://dx.doi.org/10.1007/s12576-019-00661-0 |
Ejemplares similares
-
Epac activation inhibits IL-6-induced cardiac myocyte dysfunction
por: Jin, Huiling, et al.
Publicado: (2016) -
Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice
por: Suita, Kenji, et al.
Publicado: (2015) -
Role of phosphodiesterase 4 expression in the Epac1 signaling‐dependent skeletal muscle hypertrophic action of clenbuterol
por: Ohnuki, Yoshiki, et al.
Publicado: (2016) -
Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice
por: Yagisawa, Yuka, et al.
Publicado: (2020) -
Translationally controlled tumor protein (TCTP) plays a pivotal role in cardiomyocyte survival through a Bnip3-dependent mechanism
por: Cai, Wenqian, et al.
Publicado: (2019)